Hashimoto's thyroiditis epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Hashimoto's thyroiditis}} | {{Hashimoto's thyroiditis}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
Revision as of 18:01, 18 July 2017
|
Hashimoto's thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hashimoto's thyroiditis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Hashimoto's thyroiditis epidemiology and demographics |
|
FDA on Hashimoto's thyroiditis epidemiology and demographics |
|
CDC on Hashimoto's thyroiditis epidemiology and demographics |
|
Hashimoto's thyroiditis epidemiology and demographics in the news |
|
Blogs on Hashimoto's thyroiditis epidemiology and demographics |
|
Risk calculators and risk factors for Hashimoto's thyroiditis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hashimoto's thyroiditis is particularly common in females. Annually, there are around 2–5 new cases per million people worldwide.
Epidemiology and Demographics
Hashimoto's thyroiditis is more common in females.
Prevalence
The prevalence of Hashimoto's thyroiditis is 39-79 per million.
Incidence
The overall incidence of endogenous Hashimoto's thyroiditis is approximately 2–5 new cases per million people per year.
Age
Hashimoto's thyroiditis is most prevalent between 45 and 65 years of age.
Gender
Hashimoto's thyroiditis is more common in females.
Race
There is no racial predilection for Hashimoto's thyroiditis.
Developed and Developing Countries
Hashimoto's thyroiditis is believed to be the most common cause of primary hypothyroidism in North America. In European countries, an atrophic form of autoimmune thyroiditis (Ord's thyroiditis) is more common than Hashimoto's thyroiditis. It affects between 0.1% and 5% of all adults in Western countries.